Economy
Maharashtra FDA Cancels Cipla's Pune Unit License Over Irregularities
The Hindu3h
THE BRIEF
1
The Maharashtra Food and Drug Administration cancelled the drug sale licences of Cipla Pharma & Life Sciences' Pune unit, effective August 27, 2026.
2
Regulators seized stock worth ₹11.19 lakh after finding medicines stored directly on the floor and identifying unauthorized claims on 'Reactin Plus Tablets' packaging.
3
The company failed to comply with recall directions for the misbranded tablets, leading to the license cancellation following an inspection of the Wadki warehouse.